Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Open Access

Peer-reviewed

Research Article

Rosiglitazone Treatment of Type 2 Diabetic db/db Mice Attenuates Urinary Albumin and Angiotensin Converting Enzyme 2 Excretion

  • Harshita Chodavarapu,

    Affiliation Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, United States of America

    ⨯
  • Nadja Grobe,

    Affiliation Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, United States of America

    ⨯
  • Hari K. Somineni,

    Affiliation Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, United States of America

    ⨯
  • Esam S. B. Salem,

    Affiliation Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, United States of America

    ⨯
  • Malav Madhu,

    Affiliation Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, United States of America

    ⨯
  • Khalid M. Elased

    khalid.elased@wright.edu

    Affiliation Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, United States of America

    ⨯

Viewed

Total Article Views
8,018
Apr 30, 2013 (publication date)
through Apr 01, 2025 *
MonthsCumulative Views1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253545556575859606162636465666768697071727374757677787980818283848586878889909192939495969798991001011021031041051061071081091101111121131141151161171181191201211221231241251261271281291301311321331341351361371381391401411421431441450k5k10k

*Although we update our data on a daily basis, there may be a 48-hour delay before the most recent numbers are available.

Cited

Saved

Discussed

Powered by Altmetric
Questions or concerns about usage data? Please let us know.